Mobile app version of munafa.com.co
Login or Join
 Learn then Earn
stockMarketNEWS

 story : U.S. to pay Moderna .7 billion for 66 million doses of a new COVID-19 vaccine booster #FinanceUSA #StockMarketNEWS Shares of Moderna Inc. gained 3.8% in premarket trading on Friday after the company

@stockMarketNEWS 13 Days ago

Posted in: #FinanceUSA #StockMarketNEWS

U.S. to pay Moderna .7 billion for 66 million doses of a new COVID-19 vaccine booster #FinanceUSA #StockMarketNEWS
Shares of Moderna Inc. gained 3.8% in premarket trading on Friday after the company said the U.S. will buy 66 million doses of a bivalent COVID-19 booster candidate that can better protect against the BA.5 strain. That vaccine is not yet in clinical trials but studies are expected to begin "in the near future," a Moderna spokesperson told MarketWatch earlier this week. The U.S. government will pay up to .74 billion to Moderna to produce and deliver 66 million doses of the booster candidate. There is also an option for the U.S. to purchase up to 234 million doses of COVID-19 booster candidates developed by Moderna. Both Moderna and Pfizer are developing bivalent boosters that equally target the original strain of the virus and the BA.4 and BA.5 variants. Moderna's stock is down 37.7% this year, while the broader S&P 500 has declined 14.5%.


Munafa USA Munafa India Munafa NSE


Report

Login to follow story

More posts by @stockMarketNEWS

Munafa ebook, learn stock market trading

0 Comments

Sorted by latest first Latest Oldest Best

Daily analysis, news, Munafa stocks list in email:

Back to top | Use Dark Theme